American College of Cardiology

AUGUST 31, 2024

The goal of the POPular PAUSE TAVI trial was to determine whether, in patients undergoing transcatheter aortic valve implantation (TAVI) who also take oral anticoagulation for a comorbid condition, continuation of anticoagulant therapy is noninferior to periprocedural interruption of anticoagulation with respect to major adverse cardiovascular and (..)

Aortic valve 48

Aortic valve Aortic Article 48

American College of Cardiology

MAY 29, 2024

In this week’s View, Dr. Eagle looks at the diagnostic value of aortic valve calcification levels in the assessment of low-gradient aortic stenosis.

Aortic valve 58

Aortic valve Aortic Stenosis Article 58

American College of Cardiology

JUNE 17, 2024

The goal of the BICATOR trial was to determine whether treatment with low to moderate dose atorvastatin is associated with progression of ascending aortic dilation, valvular dysfunction, or valve calcification in patients with bicuspid aortic valve.

Aortic valve 44

Aortic valve Bicuspid/Mitral Aortic Article 44

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve 64

Aortic valve Cardiac Rehabilitation Aortic TAVR 64

American College of Cardiology

APRIL 22, 2024

Is there a difference in clinical performance between different bileaflet mechanical aortic valve prostheses?

Aortic valve 56

Aortic valve Aortic Article 56

American College of Cardiology

APRIL 8, 2024

The goal of the DEDICATE-DZHK6 trial was to evaluate transcatheter aortic valve implantation (TAVI) compared with surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis and low to intermediate surgical risk.

Aortic valve 58

Aortic valve Stenosis Aortic Article 58

American College of Cardiology

MARCH 26, 2024

Blaha, MD, MPH discuss Prevalence of Aortic Valve Calcium and the Long-Term Risk of Incident Severe Aortic Stenosis. In this interview, Richard A. Chazal MD, MACC and Michael J.

Aortic valve 61

Aortic valve Aortic Stenosis Article 61

European Journal of Heart Failure

JANUARY 31, 2024

ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The use of transcatheter aortic valve replacement (TAVR) has become the preferred therapy for most patients with AS and concomitant HF.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

American College of Cardiology

APRIL 22, 2024

What is the 5-year incidence of valve reintervention after self-expanding CoreValve/Evolut transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR)?

TAVR 69

TAVR Aortic Aortic valve Stenosis 69

American College of Cardiology

JULY 23, 2024

What is the association between plasma lipoprotein(a) [Lp(a)] concentrations and hemodynamic progression in patients with aortic stenosis?

Stenosis 54

Stenosis Aortic valve Aortic Article 54

Cardiology Update

FEBRUARY 26, 2024

Transcatheter aortic valve replacement (TAVR) is the standard treatment for severe aortic stenosis, but post-TAVR leaflet thrombus, identified by hypoattenuated leaflet thickening (HALT), poses potential risks like cerebral thromboembolic events. had thrombus at any aortic valve complex. Specifically, 14.2%

TAVR 122

TAVR Aortic valve Outcomes Aortic 122

Dr. S. Venkatesan MD

APRIL 10, 2024

A 76-year-old woman with a history of double valve replacement (Aortic and mitral valves) for rheumatic heart disease, presented with acute dyspnea after a switch from Warfarin to LMWH before a planned bone marrow biopsy. Hence distal protection by an Aortic sentinel device or its equivalent (FilterWire EZ, Tri-guard) is a must.

Aortic valve 52

Aortic valve Aortic Thrombosis Bicuspid/Mitral 52

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 58

TAVR Aortic Stenosis Aortic valve 58

Frontiers in Cardiovascular Medicine

JANUARY 23, 2024

Aims The majority of patients with severe aortic stenosis (AS) planned for transcatheter aortic valve implantation (TAVI) are elective outpatients. In the present article, we report the study protocol of the ResKriVer-TAVI trial. Methods ResKriVer-TAVI will enroll AS patients planned for elective TAVI.

Aortic valve 53

Aortic valve Aortic COVID-19 Blood Pressure 53

American College of Cardiology

MARCH 22, 2024

What is the relationship between coarctation of the aorta (COA), bicuspid aortic valve (BAV), and thoracic aortic aneurysms?

Aneurysm 73

Aneurysm Aortic Aortic valve Bicuspid/Mitral 73

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2024

This concept should be applied when managing older patients with severe aortic stenosis. Although left ventricular wall hypertrophy is expected in patients with aortic stenosis, it should not be assumed that this is caused only by aortic stenosis.

Stenosis 69

Stenosis Aortic TAVR Aortic valve 69

Journal of Cardiovascular Pharmacology

NOVEMBER 21, 2023

Abstract: Transcatheter aortic valve replacement (TAVR) is an interventional procedure performed in patients with severe aortic stenosis and often required perioperative antiplatelet therapy. Most previous studies have focused on antiplatelet therapy following TAVR.

Aortic valve 40

Aortic valve Aortic TAVR Myocardial Infarction 40

Cardiology Update

JANUARY 28, 2024

The optimal management of concomitant chronic obstructive coronary artery disease (CAD) in transcatheter aortic valve replacement (TAVR) recipients remains a debated topic. Original article: Persits I et al. While some advocate for pre-TAVR percutaneous coronary intervention, others adopt an expectant approach.

TAVR 115

TAVR Aortic valve Outcomes Coronary Artery Disease 115

American College of Cardiology

JUNE 24, 2024

Greater adverse events were associated with both low and high postprocedural aortic valve mean gradient extremes following transcatheter aortic valve implantation (TAVI) for degenerated surgical aortic valve replacement (SAVR) bioprostheses, indicating a complex and nonlinear relationship between gradients and clinical outcomes, according to a recent (..)

Aortic valve 51

Aortic valve Aortic Cardiovascular Interventions Circulation 51

American College of Cardiology

MARCH 11, 2024

In these panel discussions, host Andrea Price, MS, AACC brings together Marian Hawkey, RN and Misty Theriot, BSN to explore best practices related to structural heart disease.

Aortic valve 56

Aortic valve RN Best Practices Stenosis 56

American College of Cardiology

AUGUST 31, 2024

The benefit of PCI in patients with stable coronary artery disease and severe aortic stenosis who are undergoing transcatheter aortic valve implantation (TAVI) was the focus of the NOTION-3 trial presented at ESC Congress 2024 in London.

Aortic valve 40

Aortic valve Coronary Artery Disease Aortic Stenosis 40

American College of Cardiology

MARCH 29, 2024

This technique is now employed in approximately 85% of all isolated aortic valve replacements. In the past decade, the U.S. has seen a 25-fold increase in the use of TAVR, with more than 100,000 performed annually. Despite this growth, there are notable gaps in the evidence.

Aortic 48

Aortic Bicuspid/Mitral Aortic valve Stenosis 48

American College of Cardiology

AUGUST 6, 2024

The following are key points to remember from a state-of-the-art guide to transcatheter aortic valve (TAV) design and systematic planning for a redo-TAV (TAV-in-TAV) procedure.

Aortic valve 65

Aortic valve TAVR Aortic Article 65

American College of Cardiology

AUGUST 22, 2024

For the treatment of transcatheter aortic valve (TAV) thrombosis, both in its more common form of subclinical leaflet thrombosis (SLT) and the rarer clinical valve thrombosis (CVT), pharmacotherapy with vitamin K antagonists (VKA), non-vitamin K oral anticoagulants (NOAC) and an ultraslow, low-dose infusion of thrombolytics should be considered as (..)

Thrombosis 74

Thrombosis Aortic valve Aortic Article 74

The British Journal of Cardiology

FEBRUARY 20, 2024

Case description An 80-year-old woman with severe symptomatic aortic stenosis was scheduled for transcatheter aortic valve implantation (TAVI), following Heart Team decision. Pre-procedural computed tomography (CT) angiogram revealed an area-derived annulus diameter of 23.7 mm, and calcium spur which extended from.

Aortic valve 52

Aortic valve Aortic Stenosis Article 52

American College of Cardiology

JUNE 11, 2024

In this interview, Hector I. Michelena, MD, FACC and W. Douglas Weaver MD, MACC discuss the history of and complications associated with bicuspid valvuloaortopathy.

Bicuspid/Mitral 44

Bicuspid/Mitral Aortic valve Aneurysm Aortic 44

American College of Cardiology

JULY 18, 2024

What are the national trends in utilization of leadless pacemaker implantation following transcatheter aortic valve replacement (TAVR) and its performance compared with transvenous pacemakers?

TAVR 56

TAVR Pacemaker Aortic valve Aortic 56

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 51

TAVR Aortic valve Aortic Stroke 51

American College of Cardiology

JULY 2, 2024

The goal of the LANDMARK trial was to evaluate transcatheter aortic valve replacement (TAVR) with the Myval prosthesis compared with a contemporary prosthesis among patients with symptomatic severe aortic stenosis.

Heart Valves 51

Heart Valves Aortic valve TAVR Aortic 51

American College of Cardiology

APRIL 4, 2024

What are the outcomes with transfemoral transcatheter aortic valve implantation (TAVI) in patients with pure aortic regurgitation (AR) using the Trilogy transcatheter heart valve?

Aortic valve 60

Aortic valve Heart Valves Aortic Outcomes 60

American College of Cardiology

AUGUST 5, 2024

What is the effect of the time interval between transcatheter aortic valve replacement (TAVR) and noncardiac surgery (NCS) (Δt) on the perioperative risk of major adverse events (MAEs)?

TAVR 48

TAVR Aortic valve Aortic Article 48

American College of Cardiology

FEBRUARY 17, 2024

Alain Cribier, MD, FACC, the man who pioneered the first transcatheter aortic valve replacement (TAVR), passed away on Feb. 16 at the age of 79.

Aortic valve 75

Aortic valve TAVR Aortic Article 75

American College of Cardiology

AUGUST 21, 2024

Among patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve (BEV), what are the 3-year clinical outcomes associated with a small (20 mm) compared to a larger (≥23 mm) device, and is there a relationship between the discharge echocardiographic (echo) mean gradient (MG) and measured or predicted thresholds (..)

TAVR 51

TAVR Aortic valve Outcomes Aortic 51

Journal of Cardiovascular Pharmacology

DECEMBER 12, 2023

This article is available as a PDF only. An abstract is unavailable.

Aortic valve 40

Aortic valve Article Aortic 40

Dr. S. Venkatesan MD

FEBRUARY 9, 2024

The surprise however is, TAVI was superior to cardiac surgeons in multiple aspects.The mysterious finding is TAVI had less Structural valve dysfunction , and possibly low bio valvular failure (BVF), if Kaplan -Myer curve trend is little extrapolated. No doubt ,the Aortic interventional world is applauding and everyone is joining the party.

Aortic valve 52

Aortic valve Aortic Academic Physiology 52

American College of Cardiology

APRIL 7, 2024

The goal of the SMART trial was to evaluate a self-expanding valve compared with a balloon-expandable valve among patients with aortic stenosis and a small aortic annulus undergoing treatment with transcatheter aortic valve replacement (TAVR).

Aortic valve 51

Aortic valve TAVR Aortic Stenosis 51

American College of Cardiology

MARCH 29, 2024

My patient is 59 years old, has symptomatic severe aortic stenosis (AS) with a bicuspid aortic valve (BAV), and his proximal aorta is 3.6 He has no important comorbidities and was referred for advice as to whether he should have a surgical (SAVR) or transcatheter (TAVR) aortic valve replacement. cm in diameter.

Aortic valve 40

Aortic valve Bicuspid/Mitral TAVR Aortic 40